Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
biomarkers
genetics
metastases
oligo-metastatic
prognosis
radiotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
17 Mar 2023
17 Mar 2023
Historique:
received:
23
02
2023
revised:
13
03
2023
accepted:
16
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Some cancer patients display a less aggressive form of metastatic disease, characterized by a low tumor burden and involving a smaller number of sites, which is referred to as "oligometastatic disease" (OMD). This review discusses new biomarkers, as well as methodological challenges and perspectives characterizing OMD. Recent studies have revealed that specific microRNA profiles, chromosome patterns, driver gene mutations (
Identifiants
pubmed: 36980713
pii: cancers15061827
doi: 10.3390/cancers15061827
pmc: PMC10047282
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Italian Government, Ministry of Health (www.salute.gov.it).
ID : Ricerca Corrente 2022 L4/8.
Références
Cell. 2006 Jun 16;125(6):1137-49
pubmed: 16777603
Radiother Oncol. 2020 Jul;148:157-166
pubmed: 32388150
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818803597
pubmed: 30352542
Surg Oncol Clin N Am. 2022 Apr;31(2):127-141
pubmed: 35351269
Semin Intervent Radiol. 2017 Jun;34(2):145-166
pubmed: 28579683
J Cell Biochem. 2021 Nov;122(11):1571-1578
pubmed: 34459502
Cancers (Basel). 2023 Feb 02;15(3):
pubmed: 36765907
Front Oncol. 2022 Dec 08;12:1028132
pubmed: 36568167
Eur J Surg Oncol. 2020 Mar;46(3):476-485
pubmed: 31837931
Nat Rev Cancer. 2023 Feb;23(2):78-94
pubmed: 36471053
Front Immunol. 2022 Nov 14;13:1039157
pubmed: 36451822
Transl Cancer Res. 2020 Aug;9(8):5087-5095
pubmed: 35117874
Radiat Oncol. 2014 Mar 26;9(1):85
pubmed: 24666643
Nat Commun. 2018 May 4;9(1):1793
pubmed: 29728604
Cancers (Basel). 2022 Jul 03;14(13):
pubmed: 35805034
Thorac Cancer. 2021 Feb;12(3):387-390
pubmed: 33319473
Rev Physiol Biochem Pharmacol. 2017;173:1-39
pubmed: 28456872
Curr Oncol. 2022 Mar 04;29(3):1683-1694
pubmed: 35323340
Int Rev Cell Mol Biol. 2021;364:241-265
pubmed: 34507785
Lancet Oncol. 2013 Nov;14(12):1208-15
pubmed: 24120480
Life Sci. 2018 Apr 1;198:79-86
pubmed: 29462603
J Med Case Rep. 2015 Oct 07;9:231
pubmed: 26445938
Cancer Res. 2009 May 1;69(9):3755-63
pubmed: 19383910
Lancet. 2008 Mar 22;371(9617):1007-16
pubmed: 18358928
Clin Transl Oncol. 2023 Jan;25(1):199-206
pubmed: 36068449
Discov Oncol. 2022 Aug 25;13(1):82
pubmed: 36006491
World J Clin Oncol. 2021 Sep 24;12(9):725-745
pubmed: 34631439
Thorac Cardiovasc Surg. 2023 Mar 28;:
pubmed: 36746400
Front Immunol. 2021 Feb 01;11:629722
pubmed: 33597954
Nat Rev Clin Oncol. 2017 Apr;14(4):235-246
pubmed: 27922044
Virchows Arch. 2018 May;472(5):697-703
pubmed: 29380126
Int J Mol Sci. 2020 Oct 15;21(20):
pubmed: 33076339
Nature. 2005 Jul 28;436(7050):518-24
pubmed: 16049480
Cancer Manag Res. 2023 Jan 14;15:55-65
pubmed: 36685716
Cancers (Basel). 2022 Oct 21;14(20):
pubmed: 36291943
Cancer Lett. 2008 Aug 28;267(2):262-70
pubmed: 18502035
Curr Oncol Rep. 2022 Jun;24(6):793-808
pubmed: 35298796
J Immunol. 2008 Mar 1;180(5):3132-9
pubmed: 18292536
Clin Exp Metastasis. 2022 Aug;39(4):581-588
pubmed: 35511313
Cancer Cytopathol. 2017 Jun;125(S6):455-464
pubmed: 28609003
Front Oncol. 2022 Aug 04;12:969545
pubmed: 35992784
Nat Rev Genet. 2010 Jan;11(1):31-46
pubmed: 19997069
Mol Oncol. 2022 Jan;16(2):319-332
pubmed: 34668636
Radiat Oncol. 2014 Oct 31;9:230
pubmed: 25359216
Curr Treat Options Oncol. 2021 Oct 23;22(12):108
pubmed: 34687357
Nat Methods. 2015 Sep;12(9):841-3
pubmed: 26192085
Mol Cancer Res. 2017 Mar;15(3):304-316
pubmed: 28031408
Transl Oncol. 2021 Aug;14(8):101131
pubmed: 34034007
PLoS One. 2011;6(12):e28650
pubmed: 22174856
J Clin Oncol. 1995 Jan;13(1):8-10
pubmed: 7799047
Medicine (Baltimore). 2022 Nov 18;101(46):e31918
pubmed: 36401441
Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):812-819
pubmed: 35850364
Nat Rev Cancer. 2019 Nov;19(11):639-650
pubmed: 31455892
Cancers (Basel). 2020 Oct 21;12(10):
pubmed: 33096795
Cancer Treat Rev. 2022 May;106:102382
pubmed: 35334281
Clin Transl Radiat Oncol. 2022 Nov 15;38:123-129
pubmed: 36420098
Clin Cancer Res. 2005 May 1;11(9):3353-62
pubmed: 15867235
Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):271-279
pubmed: 32223683
J Cell Physiol. 2018 Apr;233(4):2804-2814
pubmed: 28467642
Lancet Oncol. 2021 Apr;22(4):e132
pubmed: 33794210
J Clin Med. 2023 Jan 08;12(2):
pubmed: 36675442
Cancers (Basel). 2023 Feb 14;15(4):
pubmed: 36831561
J Natl Med Assoc. 1988 May;80(5):561-4
pubmed: 3047410
Curr Opin Genet Dev. 2008 Feb;18(1):3-10
pubmed: 18325755
World J Gastrointest Oncol. 2021 Dec 15;13(12):2203-2215
pubmed: 35070052
Nat Commun. 2015 Nov 06;6:8804
pubmed: 26542096
Clin Cancer Res. 2015 Aug 15;21(16):3727-39
pubmed: 25869387
Surgery. 2023 Feb;173(2):328-334
pubmed: 36400583
Cancers (Basel). 2022 Oct 23;14(21):
pubmed: 36358619
Thorac Cancer. 2022 Jul;13(13):1998-2000
pubmed: 35599247
Cell. 2018 Oct 18;175(3):751-765.e16
pubmed: 30318143
Oncol Res Treat. 2019;42(3):87-94
pubmed: 30814474
Biology (Basel). 2022 Sep 06;11(9):
pubmed: 36138802
Front Oncol. 2022 Jul 18;12:945189
pubmed: 36003767
Cell. 2018 Apr 19;173(3):581-594.e12
pubmed: 29656895
Nat Commun. 2018 Apr 23;9(1):1603
pubmed: 29686383
Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):2082-2087
pubmed: 29268653
Breast Cancer. 2012 Jul;19(3):218-37
pubmed: 22532161
Arch Pharm Res. 2021 Jan;44(1):1-15
pubmed: 33230600
N Engl J Med. 2012 Mar 8;366(10):925-31
pubmed: 22397654
Cell. 2008 Mar 7;132(5):721-3
pubmed: 18329356
Future Oncol. 2022 Jan;18(2):135-138
pubmed: 34889659
Curr Cancer Drug Targets. 2018;18(3):231-238
pubmed: 28359241
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1579-1589
pubmed: 36104632
Nat Rev Cancer. 2018 Jan;18(1):19-32
pubmed: 29217838
Crit Rev Oncog. 2006 Dec;12(3-4):273-87
pubmed: 17425506
Front Immunol. 2022 Jul 22;13:898561
pubmed: 35936004
Nat Rev Mol Cell Biol. 2018 Apr;19(4):245-261
pubmed: 29184195
Clin Lung Cancer. 2014 Sep;15(5):346-55
pubmed: 24894943
JAMA Oncol. 2018 Jan 11;4(1):e173501
pubmed: 28973074
Semin Radiat Oncol. 2006 Apr;16(2):111-9
pubmed: 16564446
Oncotarget. 2018 Oct 16;9(81):35251-35265
pubmed: 30443292
Lancet. 2019 May 18;393(10185):2051-2058
pubmed: 30982687
Nat Methods. 2021 Jun;18(6):604-617
pubmed: 34099939
Blood. 2009 Jul 16;114(3):589-95
pubmed: 19349616
Mol Endocrinol. 2008 Nov;22(11):2383-92
pubmed: 18599616
Allergy Asthma Clin Immunol. 2016 Aug 11;12:39
pubmed: 27525013
J Surg Oncol. 2012 Apr 1;105(5):468-74
pubmed: 22441898
Int J Gynecol Cancer. 2023 Feb 6;33(2):198-207
pubmed: 36229079
Oncologist. 2019 Oct;24(10):e990-e1005
pubmed: 31217342
Pulm Med. 2013;2013:438236
pubmed: 23476762
Jpn J Clin Oncol. 2010 Feb;40(2):107-11
pubmed: 20047860
Expert Rev Mol Diagn. 2022 Jan;22(1):77-100
pubmed: 34894979
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Cancer J. 2020 Mar/Apr;26(2):137-143
pubmed: 32205538
Cancer Immunol Res. 2013 Dec;1(6):365-72
pubmed: 24563870
Methods Mol Biol. 2019;1897:359-383
pubmed: 30539458
Curr Opin Oncol. 2013 Jan;25(1):76-84
pubmed: 23197193
Cell Death Dis. 2020 Apr 24;11(4):275
pubmed: 32332709
J Natl Cancer Inst. 2022 Jan 30;:
pubmed: 35094066
Biosensors (Basel). 2021 Jun 30;11(7):
pubmed: 34208844
Medicine (Baltimore). 2020 Jan;99(1):e18530
pubmed: 31895788
Int J Mol Med. 2018 Oct;42(4):1771-1785
pubmed: 30015855
Cancers (Basel). 2022 Sep 08;14(18):
pubmed: 36139545
Nat Rev Genet. 2016 Oct 14;17(11):704-714
pubmed: 27739533
J Clin Oncol. 2019 Jun 20;37(18):1558-1565
pubmed: 31067138
Evid Based Complement Alternat Med. 2022 Sep 24;2022:5067402
pubmed: 36193130
Int J Gynecol Cancer. 2022 Jul 22;:
pubmed: 35868655
Transl Cancer Res. 2020 Aug;9(8):5028-5031
pubmed: 35117867
Future Oncol. 2021 Sep;17(26):3529-3539
pubmed: 34254524
Hepatobiliary Surg Nutr. 2020 Feb;9(1):49-58
pubmed: 32140478
Semin Cancer Biol. 2020 May;62:192-200
pubmed: 31518697
J Cell Biochem. 2009 Feb 1;106(2):210-9
pubmed: 19097084
Lancet Oncol. 2020 Jan;21(1):e18-e28
pubmed: 31908301